Doppel is a leading Italian, finished dose contract development and manufacturing organization (CDMO) with aggressive plans for expanding its presence in international markets. Backed by a private equity firm with a strategic outlook, the company has been investing in new capabilities and capacities designed to meet the evolving needs of its customers. Recent U.S. Food and Drug Administration (FDA) approval of solid oral dose manufacturing at our Rozzano facility in Milan, Italy is just one of many steps the firm is taking to internationalize its